CellaVision AB (CHIX:CEVIs)

Q4 2024 CellaVision AB Earnings Call Transcript

Feb 6, 2025 / 10:00 AM GMT

Release Date Price: kr177.2

Transcript

Key Points

Positve

CellaVision AB (CLVSF) achieved all-time high sales in the APAC region, demonstrating strong regional performance.
The company reported a strong gross margin of 69%, attributed to a favorable product mix, particularly in the instrument category.
CellaVision AB (CLVSF) has made significant progress in its strategic alliance with SysMex Corporation, achieving double-digit growth.
The company is advancing its innovation agenda, with substantial investments in next-generation digital cell morphology analyzers.
CellaVision AB (CLVSF) reported a 33% EBITDA margin, aligning with its annual target of 30% or more, despite regional sales variability.

Negative

CellaVision AB (CLVSF) experienced a 7% decline in overall growth for the quarter, with notable sales challenges in the Americas.
The company faced a decline in the MEA region, attributed to a higher Q3 performance that impacted Q4 revenues.
Operating expenses increased to 42% of sales, partly due to compliance costs and increased R&D spending.
CellaVision AB (CLVSF) reported a significant drop in operating cash flow, primarily due to inventory buildup in the US.
The company is experiencing delays in order placements and installations in the Americas, impacting sales performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CEVI.ST - CellaVision AB
Q4 2024 CellaVision AB Earnings Call
Feb 06, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you very much.

And thank you everybody for dialing into our Q4 report 2024.

I have Magnus Blixt next to me, our CFO, and I'm pleased to present, and we're pleased to answer any questions you may have after the report.

So the report that we have announced today, we have entitled it Mixed Regional Performance sales peaking in APAC.

And I'm pleased to go through the results, both top line, our P&L, regional splits, product categories, and a little bit around the strategic situation.

So the quarter in brief, as I said, we highlighted the report, mixed regional performance in the quarter.

And that is certainly seen by swings negatively in Americas, pretty modest in Europe, in the,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.